drugset / Trial / NCT01493882
Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of JNJ-39758979 compared with placebo in patients with uncontrolled asthma despite current treatment with inhaled corticosteroids and/or long-acting beta 2-agonist (LABA) and/or montelukast for at least 4 weeks.
Timeline
- Start
- 2012-03
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-39758979 | Small molecule | 30 mg | Oral |
| Subject | JNJ-39758979 | Small molecule | 100 mg | Oral |
| Subject | JNJ-39758979 | Small molecule | 300 mg | Oral |